Lectures and seminars

Peter Gasser: LSD-assisted psychotherapy in group format

Denna sida på svenska
2017-10-3018:00 to 20:00 Hörsal Vesalius, Berzelius väg 3Campus Solna

The Network for Psychedelic Science have the great honor of introducing the Swiss psychiatrist Peter Gasser as guest lecturer at Karolinska Institutet.

With both clinical and preclinical experience, few people in the world can measure up to Peter's overall knowledge in psychedelic therapy. Almost three decades ago, Peter was one of only five doctors legally allowed to use MDMA and LSD in clinical psychotherapy in Switzerland between 1988 and 1993. In 2007, Peter started the first controlled clinical trial with LSD for over 40 years, providing support that LSD can have a good effect on anxiety at the end of life [1,2]. Peter has continued his research on LSD and LSD-Assisted Psychotherapy [3,4], and is currently conducting a study on LSD-assisted psychotherapy in group format.

On October 30th, Peter will give an overview of how to work therapeutically with LSD, as well as sharing preliminary findings from the ongoing study. The lecture is free and no pre-registration required, but the number of seats is limited. Participants are advised to arrive on time to secure a place. Welcome!

[1] Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, Brenneisen R. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis. 2014 Jul;202(7):513-20.

[2] Gasser P, Kirchner K, Passie T. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. J Psychopharmacol. 2015 Jan;29(1):57-68.

[3] Schmid Y, Enzler F, Gasser P, Grouzmann E, Preller KH, Vollenweider FX, Brenneisen R, Müller F, Borgwardt S, Liechti ME. Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects. Biol Psychiatry. 2015 Oct 15;78(8):544-53.

[4] Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T. Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Sep 22. pii: S0278-5846(17)30636-X.

Contact person: Alexander Lebedev